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Glycoproteins IIb/IIIa form a  Ca2+-dependent complex that functions as the 
fibrinogen receptor on human platelets (1).  Several reports have indicated that 
this fibrinogen receptor is also expressed  on  the surface of human monocytes 
(2-4).  Of three  monoclonal antibodies  directed against  platelet  IIb/IIIa,  two 
were  reported  to  give  a  positive  reaction  with  monocytes as  well  (4).  Other 
investigators  reported  that,  in  patients  with  Glanzmann's  thrombasthenia,  a 
bleeding disorder characterized by the absence of or marked reduction in IIb/ 
IIIa on platelets, both glycoproteins were also missing in monocytes (3).  It has 
also been  shown that monocytes bind fibrin (5,  6),  which would be consistent 
with the presence of a fibrinogen receptor on their surface. 
The  presence  of IIb/IIIa  on  monocytes would offer a  good opportunity to 
study the biosynthesis and molecular biology of these glycoproteins and hence 
to determine the genetic defect in bleeding disorders like Glanzmann's throm- 
basthenia.  Monocytes are  accessible  in  large  numbers  and  are  easily  kept  in 
culture, in contrast to megakaryocytes, the platelet precursor cells. 
Despite  much evidence,  however,  the presence  of IIb/IIIa on  mononuclear 
phagocytes is still not fully established. Monocytes that are isolated from blood 
are often contaminated with adherent platelets unless scrupulous precautions are 
taken  (7-9).  Thorough  washing may remove  most  platelets  but  fragments of 
platelet membrane can remain attached to the monocyte surface by an interaction 
mechanism that is still unclear. We have recently worked out a  method for the 
large  scale preparation  of highly purified monocytes from donor blood  using 
centrifugal elutriation. Since our preparations were virtually free of platelets, we 
decided to reinvestigate IIb/IIIa on mononuclear phagocytes. Using two differ- 
ent techniques based on mono- and polyclonal antibodies, as well as immunoe- 
lectron microscopy, we found no evidence for the presence of these glycoproteins 
on monocytes and monocyte-derived macrophages. 
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Materials and  Methods 
Platelets.  Human  blood  platelets  were  isolated,  within  20  h  after  donation,  from 
citrated blood (Central Laboratory, Blood Transfusion Service, Swiss Red Cross, Bern) 
washed, and labeled as described by Steiner et al. (10). 
Monocytes.  Pure  monocyte  populations  were  obtained  essentially  according  to  the 
method of Leijh et al. (11) with minor modifications. Briefly, citrated blood from healthy 
donors was centrifuged at room temperature on  Lympho-paque (Nyegaard Co.,  Oslo, 
Norway) containing 0.6 mM sodium citrate. Cells from the interphase were washed once 
at  10 °C with phosphate-buffered saline containing  1 U/ml heparin,  then washed three 
times in 4% pasteurized plasma protein solution (PPL SRK 4%; Swiss Red Cross) contain- 
ing 0.5  mM EDTA.  Monocytes were then isolated from this population by centrifugal 
elutriation  using  a  JE6  elutriator  rotor  operated  by  a  refrigerated J6-M  centrifuge 
(Beckman Instruments, Inc., Palo Alto, CA). The elutriation medium consisted of Ca  ++ 
and  Mg÷+-free phosphate-buffered saline,  pH  7.4,  containing  0.01%  EDTA  and  1% 
bovine serum albumin. The flow rate was kept constant (18 ml/min), the temperature 
was 10 ° C, and the rotor speed was reduced stepwise from 3,130 to 2,100 rpm. Monocytes 
were collected in two 45-ml fractions, at each speed (2,430,  2,330, and 2,230 rpm) and 
kept in ice. The cells were washed once (250 g for 10 rain) in Dulbecco's modified Eagle's 
medium  (DME) I (Gibco,  Basle) and either  used  directly or  cultured  for 4  d  in  DME 
containing 3% pooled group AB human serum (Swiss Red Cross). 
The purity of the monocyte preparations used in these experiments was >90%, judged 
morphologically after Giemsa staining and by peroxidase and esterase histochemistry, as 
well as by fluorescence-activated cell sorter analysis using anti-Leu-M3 antibody (Becton, 
Dickinson & Co., Mountain View, CA). 
Surface Labeling  and  Immunoprecipitation.  Monocytes (5  ×  107) were labeled by the 
periodate/[3H]NaBH4 method as adapted for platelets by Steiner et al. (10). After washing, 
the monocytes were solubilized in 400 #l of 0.15 M NaCI, 0.005 M EDTA, 0.5% Nonidet 
P-40, 0.05 M Tris-HCI, pH 7.4, followed by centrifugation at 100,000 g for 30 rain. The 
supernatant was used for immunoprecipitation and for two-dimensional gel electropho- 
resis. 
Immunoprecipitation was performed overnight at  4°C  by incubating  100  t~i  of the 
solubilized ~H-labeled monocyte preparation with 50 ~! of rabbit antiplatelet IgG prepared 
according to Hagen et al. (12). Goat anti-rabbit Immunobeads (4 rag; Bio-Rad Laborato- 
ries,  Richmond,  CA)  were added and  the  mixture incubated  for a  further  4  h.  The 
Immunobeads were washed three times with 0.15 M NaCI, 0.005 M EDTA, 0.5 Nonidet 
P-40,  0.05  M  Tris-HC1, pH  7.4 buffer; then  100/~1  of 0.125  M  Tris-HCl, 2% sodium 
dodecyl sulfate (SDS),  pH 6.8 were added and the mixture was heated to  100°C for 2 
min. The supernatant was directly used for SDS-polyacrylamide gel electrophoresis. 
Gel Electrophoresis.  One- and two-dimensional gel electrophoresis of immunoprecipi- 
tates and radiolabeled platelet and monocyte preparations were carried out;  gels were 
prepared for fluorography and  exposed to  Kodak X-Omat SO-282  film as previously 
described (13). 
Crossed Immunoelectrophoresis.  Supernatants  from solubilized platelet and  monocyte 
preparations (80 #g protein) were separated by crossed immunoelectrophoresis against 
rabbit antiplatelet  antibodies  essentially  as  described  by  Hagen  et  al.  (12).  The  first 
dimension consisted of 1% agarose in  1% Triton X-100, 0.038  M Tris, 0.1  M glycine, 
pH  8.7.  Electropboresis  was  carried  out  at  10  V/cm  for  1  h  at  10°C.  The  second 
dimension was performed on Gel Bond film (FMC Corp., Chicago, IL) in  1% agarose at 
2  V/cm for  18  h  at  10°C.  An intermediate gel contained  l~SI-labeled  P4 (0.1  #g/cm  2) 
monoclonal antibody to glycoproteins IIb/IIIa (14),  while the main gel contained poly- 
clonal rabbit antiplatelet antibodies (11/~g/cm  2) either purchased from Dakopatts, Copen- 
hagen, Denmark or prepared by repeated injection of washed human platelets into New 
Zealand rabbits.  The gels were washed,  stained  with  Coomassie Blue,  and dried.  The 
I Abbreviations used  in  this paper:  DME, Dulbecco's modified  Eagle's medium;  SDS, sodium 
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dried gels were exposed to  Kodak X-Omat SO-282 film between two Dupont Cronex 
Lightning Plus intensifying screens (DuPont Co., Wilmington, DE). 
Labeling of Monoclonal Antibody.  The P4 monoclonal antibody (100 #g) was labeled 
with ~5I (1 mCi) using the chloramine T  method (15). The labeled mixture was applied 
to a  Sephadex G25 column, and the excluded peak was collected, protein content and 
radioactivity determined, and aliquots stored at -70 o  C. 
Immunocytochemical  Procedures.  Platelets and monocytes separated from human blood 
by the Ficoll-Hypaque method were fixed in 2% paraformaldehyde and 0.05% glutaral- 
dehyde in 0.1  M phosphate buffer for I  h at 37°C, and were subsequently washed and 
processed as  described  by  Stenberg et  al.  (16).  They were  then  treated  with  mouse 
monoclonal antibody to platelet IIb/IIIa (T 10; reference 17) followed by goat anti-mouse 
antibodies linked to colloidal gold 0anssen Pharmaceuticals, Beerse, Belgium) at a dilution 
of  1:20.  Cells  processed with  colloidal gold immunoconjugates were  postfixed in  1% 
OsO4, exposed to uranyl acetate, and then processed for transmission electron microscopy. 
Results 
Surface Labeling and lmmunoprecipitation.  Monocytes were isolated by elutria- 
tion and surface labeled by a variant of the periodate/[3H]NaBH4 technique (10). 
After solubilization and centrifugation, the supernatant was either separated by 
two-dimensional polyacrylamide gel electrophoresis (Fig.  1) or used for immu- 
noprecipitation with  rabbit  antiplatelet antibodies  and  then  analyzed by SDS- 
polyacrylamide gel electrophoresis (Fig.  2).  Surface labeled platelets were  used 
in parallel as a positive control (Fig. 2). 
The  two-dimensional  separations  showed  completely  different  patterns  for 
platelets and monocytes. No spot in the monocyte fluorogram corresponded to 
the normal positions of platelet IIba, IIIa, or IIb¢~ (compare Fig.  1, a  and b).  A 
normal pattern of platelet surface glycoproteins was obtained after electropho- 
FIGURE  1.  Fluorograms of two-dimensional polyacrylamide gel electrophoresis separations 
of cells surface-labeled  by the periodate/[SH]NaBH4  technique. (a) Human blood platelets; the 
glycoproteins that  have  been  reported to  occur  in  monocytes are  indicated. (b)  Human 
monocytes; the position of the major glycoproteins is indicated (GPI60)  as are the positions 
where the platelet IIb/IIIa complex would be expected (arrows). CLEMETSON ET  AL.  975 
FIGURE 2.  Fluorogram of one-dimensional SDS-polyacrylamide  gel electrophoresis  of cells 
surface-labeled by the periodate/[3H]NaBH4  technique, and of immunoprecipitates with rabbit 
antiplatelet antibodies. (a) Human blood platelets. (b) Immunoprecipitate platelets. (c) Human 
monocytes. (d) lmmunoprecipitate monoeytes. The original fluorogram of d showed faint 
bands corresponding to the main bands in c. 
retic analysis of immunoprecipitates of solubilized platelet samples (Fig. 2, a and 
b). No bands corresponding to the major platelet glycoproteins, however, could 
be identified on electrophoresis of the monocyte samples subjected to the same 
immunoprecipitation  procedure (Fig.  2 d). Very faint bands were found on the 
latter gel corresponding to some monocyte glycoproteins (Fig. 2, c and d).  They 
are  probably  due  to  nonspecific  precipitation  since  they  were  also  present  in 
control  samples  that  were  immunoprecipitated  using  preimmunization  rabbit 
serum (not shown). 
Crossed Immunoelectrophoresis.  Solubilized samples of freshly prepared  mon° 
ocytes and platelets and of monocyte-derived macrophages obtained after 4 d in 
culture were used. Platelet preparations  were solubilized either in the presence 
of Ca  2+ (5 raM) or EDTA (5 mM) because of the known Ca  2÷ dependence of the 
IIb/IIIa complex (1). 
All  samples  were  then  subjected  to  crossed  immunoelectrophoresis  against 
rabbit anti-whole platelet antibodies using 125I-labeled  monoclonal anti IIb/IIIa 
antibody (P4; reference  14) in an  intermediate  gel.  As shown by Fig.  3, in  the 
platelet sample a heavy precipitation  arc characteristic of IIb/IIIa was obtained 
(Fig. 3 a), which was strongly labeled by the monoclonal antibody in the autora- 
diograms (Fig. 3 b). No other arc was revealed by this antibody. The gels obtained 976  PLATELET  MEMBRANE  GLYCOPROTE|NS  AND  MONOCYTES 
FIGURE 3.  Crossed immunoelectrophoresis  studies with solubilized platelets and monocytes 
and a monoclonal  antibody to platelet  glycoproteins  IIb/IIIa. (a) Coomassie Blue-stained gel 
of 80 ~g of platelet protein solubilized in 1% Triton X-100 in the absence of EDTA, with 125I- 
labeled  anti-lib/Ilia  monoclonal  antibody (P4) in the intermediate gel. The upper gel con- 
tained polyclonal rabbit anti-human platelet  antibodies.  (b) Autoradiogram of gel shown in a. 
(c) Coomassie Blue-stained gel of 80 #g of protein from fresh  monocytes solubilized in  1% 
Triton X-100 in the absence  of EDTA, with  t~SI-labeled anti-IIb/IIIa monoclonal antibody 
(P4) in the intermediate gel. The upper gel contained polyclonal rabbit anti-human platelet 
antibodies. 
with the mononuclear phagocyte samples showed much less staining.  No precip- 
itation  arc  could  be  identified  from  fresh  monocytes  (Fig.  3c),  which  were 
completely  negative  on  prolonged  autoradiography  (Fig.  3 d).  Coomassie  Blue 
staining of the gels obtained from monocytes cultured for 4 d  revealed one major 
arc  corresponding  to  albumin  and  some  minor  ones  that  probably  also  repre- 
sented serum proteins taken up from the culture medium (not shown). Only one, CLEMETSON  ET  AL.  977 
very faint arc was detectable on autoradiography (not shown), corresponding to 
the albumin precipitate. 
Immunocytochemical Demonstration of Hb/Illa.  Mixtures  of  monocytes  and 
platelets were fixed, treated with monoclonal antibody to IIb/IIIa (T10; refer- 
ence  17), treated with goat anti-mouse IgG coupled to gold particles, and then 
processed for electron  microscopy. Figs.  4,  5,  and  6  show typical examples of 
platelets and monocytes in close proximity. While the platelet membranes show 
regular tagging with gold, the monocyte membranes are virtually free of label. 
In the rare instances where gold particles were present near monocyte surfaces, 
closer  examination  revealed  their  association  with  a  fragment  of membrane, 
presumably derived from a platelet. 
Discussion 
Two different immunochemical  techniques were applied to the identification 
of glycoproteins lib/Ilia in platelets, monocytes, and monocyte-derived macro- 
phages from human blood. Both detected the glycoproteins in platelets but not 
in  mononuclear  phagocyte preparations.  Compatible  results were obtained by 
immunochemistry using a monoclonai antibody against the platelet glycoproteins 
(revealed by a gold-labeled second antibody), which bound heavily to the platelet 
but not to the monocyte surface. 
The presence ofa platelet-like fibrinogen receptor on mononuclear phagocytes 
has been a much debated question over the past few years. Most reports to date 
have suggested that IIb/IIIa are indeed common to both cells. Our results now 
show that this is most probably not the case. The inherent problem in studies of 
this  nature  is obtaining  platelet-free  monocytes to analyze.  Platelets adhere  to 
the monocytes and,  unless special precautions are taken, most monocytes carry 
a  few platelets on  their  surface.  This  problem  has  been discussed in  detail  by 
Pawlowsky et ai. (9) and also addressed by other authors (7, 8).  Whole platelets 
associated with monocytes are easily seen but membrane  fragments of platelets 
disrupted by the preparation  method may escape detection.  Even sophisticated 
treatments  to dissociate the platelet-monocyte microaggregates are only partial 
solutions. 
Evidence for the presence of IIb/IIIa on monocytes falls into three categories: 
detection on monocytes themselves (2, 4); the failure to detect these glycoproteins 
on  monocytes from patients  with  Glanzmann's  thrombasthenia  (3) (a bleeding 
disorder  characterized  by  the  absence  or  marked  reduction  of  lib/Ilia  on 
platelets); and detection on cell lines of a monocytic nature (2, 4). 
The absence of lib/Ilia on monocytes from Gianzmann's  thrombasthenia  (3) 
may then be attributed either to their absence from the platelets or to the lower 
tendency  of such  platelets  to  aggregate  and  be activated  (18).  Treatment  of 
monocytes  with  EDTA  has  been  described  as  an  effective way  of removing 
adhering platelets (5, 8). It is known that platelets treated with EDTA no longer 
aggregate in response to a variety of stimuli (19), and this has been shown (1) to 
be related to the dissociation of the lib/Ilia complex, which is Ca2÷-dependent 
and  which  acts  as  the  fibrinogen  receptor  on  the  platelet  (1).  Glanzmann's 
thrombasthenia  platelets also fail to aggregate  to the same stimuli (I 8).  There- 
fore, it would not be surprising  if thrombasthenic  platelets also do not stick to 978  PLATELET  MEMBRANE  GLYCOPROTEINS  AND  MONOCYTES 
FIGURE 4.  Transmission electron micrograph of monocyte (M) and platelets (P) from human 
blood. Notice the frequent clumping of platelets next to the monocyte. In addition, these cells 
were  processed  for  the  immunocytochemical  localization  of  the  monoclonal  antibody  for 
glycoproteins I Ib/I I la using the immunogold probe GAM-5. It is difficult to appreciate at this 
magnification, but  the plasma  membranes of the platelets are  heavily labeled,  in a  patchy 
manner, along their entire extent, while the plasma membrane of the monocyte is free of gold 
particles.  The area  marked  by the arrow  can be seen at  higher magnification in  Fig.  6.  x 
17,000. CLEMETSON  ET  AL.  979 
FIGURE 5.  A higher- magnification view of a portion of the cells seen in Fig. 5., more clearly 
illustrating the presence of gold particles along the platelet (P) plasma membrane and their 
absence  from  the  monocyte (M)  plasma  membrane.  Small portions  of platelet  membranes 
(arrowheads) have been sectioned and are also labeled with gold particles. ×  66,000. 980  PLATELET  MEMBRANE  GLYCOPROTEINS  AND  MONOCYTES 
FIGURE  6.  A  low-magnification view of two monocytes (M) and adjacent platelets (P).  Note 
the presence of immunogold label for lib/Ilia on platelet membrane and its absence from the 
monocyte membranes. The small circular patch of label on the left (arrowhead) is not on the 
monocyte membrane and is probably a grazing section through the tip of platelet pseudopod. 
(a) X  11,000; (b) X  55,000. CLEMETSON  ET  AL.  981 
monocytes.  However,  we  cannot  yet  distinguish  whether  platelet  membrane 
fragments  are  absent  on  thrombasthenic  monocytes  due  to  the  platelets  not 
sticking or if we are unable to detect these fragments because they do not contain 
IIb/IIIa. 
Another line of evidence in favor of the presence of IIb/IIIa on mononuclear 
phagocytes is their  detection on several cell lines (4,  20).  The  use of cell lines 
avoids  the  problem  of contamination  by  platelets,  but  does  not  reveal  the 
properties of mononuclear phagocytes, since these lines are derived from leuke- 
mia or lympboma patients and may be incompletely or incorrectly differentiated. 
The  HEL  line,  for  example,  expresses  both  erythrocyte  and  megakaryocyte 
membrane  markers,  including  IIb/IIIa (21).  Even in  cell lines such as  HL-60, 
the expression of IIb and IIIa is controversial, having been found by two groups 
(2, 4) but not by a third (20). 
One of the  principal  arguments  (4) in  favor of the  presence  of IIb/IIIa  on 
monocytes, based on studies with cell lines, was that two out of three monoclonal 
antibodies, which react with IIb/IIIa on platelets, selectively bind to both mon- 
ocytes and  cell  lines  of monocytic  character.  The  remaining  monoclonal  is, 
however, capable of precipitating  the IIb/IIIa complex. The authors suggested 
that the IIb/IIIa complex might have a different conformation on the monocyte 
than  in  platelets.  Since  little  is  known  of  the  epitopes  or  avidity  of  these 
monoclonals, a simpler explanation cannot be excluded, namely that this mono- 
clonal has a  lower avidity and  reacts poorly with the lower density of IIb/IIIa 
found on cell lines or on the fragments of platelets associated with monocytes. 
Our studies failed to detect glycoproteins IIb/IIIa in preparations of 2 ×  107 
mononuclear cells, using techniques that would detect the glycoproteins in  106 
platelets. This shows that the monocyte preparations contained <5% of platelets 
on  a  per  cell  basis  or  0.4%  on  a  surface  membrane  basis.  The  latter  figure 
assumes a diameter of 10 tim for a monocyte (22) and 0.96 and 3.72 #m for the 
axial  and  equatorial  diameters,  respectively,  of a  discoid  platelet  (23).  Our 
inability to detect platelets in  these preparations  by either  microscopic or bio- 
chemical techniques indicates that centrifugal elutriation  yields monocytes with 
minimal contamination by platelets. It is difficult from published work to estimate 
the  levels of IIb/IIIa  found on  monocyte preparations,  but  these  seem to be 
comparable  to  the  amounts  present  on  type  II  Glanzmann's  thrombasthenia 
platelets (24),  which are ~ 10% of those present on normal  platelets.  Since the 
techniques we have used would detect lower amounts than  this,  it seems likely 
that the positive results of other authors were due to undetected contamination 
of the monocytes by platelet fragments. 
Summary 
Two-dimensional  gel electrophoresis,  immunoprecipitation,  and  crossed im- 
munoelectrophoresis were used in the investigation of glycoproteins IIb/IIIa in 
platelets,  monocytes, and  monocyte-derived macrophages  from  human  blood. 
All techniques detected the glycoproteins in platelets but not in the mononuclear 
phagocytes.  Similar  results were obtained by immunochemistry  using a  mono- 
clonal antibody against  the platelet glycoproteins IIb/IIIa (revealed by a  gold- 
labeled second  antibody)  which  bound  heavily  to  the  platelet  but  not  to  the 982  PLATELET MEMBRANE GLYCOPROTE1NS AND  MONOCYTES 
monocyte surface.  The biochemical techniques  used for the analysis of mono- 
nuclear phagocytes would have reliably detected the level of glycoproteins IIb/ 
IIIa contributed by a  5% contamination with platelets, calculated on a  per cell 
basis. 
We conclude that human monocytes and monocyte-derived macrophages lack 
glycoproteins IIb/IIIa.  Our results further indicate that centrifugal elutriation 
yields monocyte preparations with minimal contamination by platelets. It seems 
likely that the positive results obtained by other authors were due to the presence 
of platelets or fragments on the monocytes. 
We thank Miss M.-L. Zahno and Mr. P.  Mauderli for technical assistance and Dr. D. A. 
Deranleau for calculating the surface area of a platelet. 
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